ASHLEIGH DUBANIK: Open Payments
NPI 1487437430 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 44 payments from 14 companies in 2025. Trend: 2023 $276 · 2024 $1,076 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $238 |
| ALK-Abello, Inc | 4 | $196 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $190 |
| AstraZeneca Pharmaceuticals LP | 6 | $138 |
| ABBVIE INC. | 4 | $87 |
| Lilly USA, LLC | 3 | $57 |
| Astellas Pharma US Inc | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| PFIZER INC. | 1 | $24 |
Products named: Odactra, XIFAXAN, Wegovy, AIRSUPRA, MOUNJARO, Veozah, VRAYLAR, Ozempic.
Industry payments across NY — which companies pay providers there.
